IL-22R Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of IL-22R monoclonal antibodies for research focused on understanding the interleukin-22 receptor. IL-22R monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The interleukin-22 receptor mediates the effects of interleukin-22, a cytokine involved in immune responses and tissue homeostasis. IL-22R plays a significant role in regulating inflammation and maintaining epithelial barrier function, making it a key target for studies related to autoimmune diseases and infections. Research has shown that IL-22R expression is tightly regulated in specific cell types, particularly epithelial cells. The receptor's activation triggers multiple downstream signaling cascades that influence cell survival, proliferation, and antimicrobial defense mechanisms. Understanding IL-22R signaling pathways can reveal potential therapeutic strategies for various inflammatory conditions. Investigating IL-22R interactions with its ligands provides valuable information about immune system regulation and tissue repair processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of IL-22R biology and its impact on human health.